176 related articles for article (PubMed ID: 29165639)
41. Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer.
Distefano R; Tomasello L; Rampioni Vinciguerra GL; Gasparini P; Xiang Y; Bagnoli M; Marceca GP; Fadda P; Laganà A; Acunzo M; Ma Q; Nigita G; Croce CM
Cancer Res; 2022 Oct; 82(20):3687-3700. PubMed ID: 36040379
[TBL] [Abstract][Full Text] [Related]
42. ADAR1-Mediated RNA Editing and Its Role in Cancer.
Liu J; Wang F; Zhang Y; Liu J; Zhao B
Front Cell Dev Biol; 2022; 10():956649. PubMed ID: 35898396
[TBL] [Abstract][Full Text] [Related]
43. The Epitranscriptome in miRNAs: Crosstalk, Detection, and Function in Cancer.
Del Valle-Morales D; Le P; Saviana M; Romano G; Nigita G; Nana-Sinkam P; Acunzo M
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886072
[TBL] [Abstract][Full Text] [Related]
44. Reduction of A-to-I RNA editing in the failing human heart regulates formation of circular RNAs.
Kokot KE; Kneuer JM; John D; Rebs S; Möbius-Winkler MN; Erbe S; Müller M; Andritschke M; Gaul S; Sheikh BN; Haas J; Thiele H; Müller OJ; Hille S; Leuschner F; Dimmeler S; Streckfuss-Bömeke K; Meder B; Laufs U; Boeckel JN
Basic Res Cardiol; 2022 Jun; 117(1):32. PubMed ID: 35737129
[TBL] [Abstract][Full Text] [Related]
45. Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer.
Zhang S; Kuang G; Huang Y; Huang X; Wang W; Wang G
Hum Genomics; 2022 Apr; 16(1):14. PubMed ID: 35449086
[TBL] [Abstract][Full Text] [Related]
46. Disparities in Lung Cancer: miRNA Isoform Characterization in Lung Adenocarcinoma.
Distefano R; Nigita G; Le P; Romano G; Acunzo M; Nana-Sinkam P
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159038
[TBL] [Abstract][Full Text] [Related]
47. Quantification of microRNA editing using two-tailed RT-qPCR for improved biomarker discovery.
Voss G; Edsjö A; Bjartell A; Ceder Y
RNA; 2021 Nov; 27(11):1412-1424. PubMed ID: 34433636
[TBL] [Abstract][Full Text] [Related]
48. Epitranscriptomics: A New Layer of microRNA Regulation in Cancer.
De Paolis V; Lorefice E; Orecchini E; Carissimi C; Laudadio I; Fulci V
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282776
[TBL] [Abstract][Full Text] [Related]
49. The MicroRNA Family Gets Wider: The IsomiRs Classification and Role.
Tomasello L; Distefano R; Nigita G; Croce CM
Front Cell Dev Biol; 2021; 9():668648. PubMed ID: 34178993
[TBL] [Abstract][Full Text] [Related]
50. Detecting and Characterizing A-To-I microRNA Editing in Cancer.
Marceca GP; Tomasello L; Distefano R; Acunzo M; Croce CM; Nigita G
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916692
[TBL] [Abstract][Full Text] [Related]
51. Non-Coding RNAs in Cancer Diagnosis and Therapy: Focus on Lung Cancer.
Le P; Romano G; Nana-Sinkam P; Acunzo M
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803619
[TBL] [Abstract][Full Text] [Related]
52. Editing and Chemical Modifications on Non-Coding RNAs in Cancer: A New Tale with Clinical Significance.
Torsin LI; Petrescu GED; Sabo AA; Chen B; Brehar FM; Dragomir MP; Calin GA
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430133
[TBL] [Abstract][Full Text] [Related]
53. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
[TBL] [Abstract][Full Text] [Related]
54. Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.
Kim WR; Park EG; Kang KW; Lee SM; Kim B; Kim HS
Mol Cells; 2020 Nov; 43(11):953-963. PubMed ID: 33199671
[TBL] [Abstract][Full Text] [Related]
55. Succinate Dehydrogenase and Ribonucleic Acid Networks in Cancer and Other Diseases.
Moreno C; Santos RM; Burns R; Zhang WC
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33153035
[TBL] [Abstract][Full Text] [Related]
56. Adenosine-to-Inosine Editing of Vasoactive MicroRNAs Alters Their Targetome and Function in Ischemia.
van der Kwast RVCT; Parma L; van der Bent ML; van Ingen E; Baganha F; Peters HAB; Goossens EAC; Simons KH; Palmen M; de Vries MR; Quax PHA; Nossent AY
Mol Ther Nucleic Acids; 2020 Sep; 21():932-953. PubMed ID: 32814251
[TBL] [Abstract][Full Text] [Related]
57. Non-Coding RNA Editing in Cancer Pathogenesis.
Romano G; Saviana M; Le P; Li H; Micalo L; Nigita G; Acunzo M; Nana-Sinkam P
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32650588
[TBL] [Abstract][Full Text] [Related]
58. Bioinformatics Analysis of Evolution and Human Disease Related Transposable Element-Derived microRNAs.
Lee HE; Huh JW; Kim HS
Life (Basel); 2020 Jun; 10(6):. PubMed ID: 32630504
[TBL] [Abstract][Full Text] [Related]
59. The cell line A-to-I RNA editing catalogue.
Schaffer AA; Kopel E; Hendel A; Picardi E; Levanon EY; Eisenberg E
Nucleic Acids Res; 2020 Jun; 48(11):5849-5858. PubMed ID: 32383740
[TBL] [Abstract][Full Text] [Related]
60. Adenosine-to-inosine RNA editing in the immune system: friend or foe?
Nakahama T; Kawahara Y
Cell Mol Life Sci; 2020 Aug; 77(15):2931-2948. PubMed ID: 31996954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
